Mechanism of Action of Belimumab
Introduction Belimumab is a human IgG1λ monoclonal antibody used in the treatment of autoimmune lupus disorders. It is marketed under the brand name Benlysta and is classified as a B-lymphocyte stimulator-specific inhibitor, also called a BLyS inhibitor or BAFF inhibitor. Belimumab is used in patients 5 years of age and older with active systemic lupus … Read more